AbbVie extended the patent life on Humira for years, enough time to more than replace the sales. Now Merck and Bristol Myers ...
The PTFE Membrane Market is poised for growth due to rising pharmaceutical demands and stricter water treatment regulations.
Data update from the ongoing Phase 1b/2 study of muzastotug + pembrolizumab in 3L+ MSS CRC patients remains on track for Q1 ...
Astellas' CEO said he doesn't want to make acquisitions simply to fill a revenue gap. Takeda is preparing for Trintellix's U.S. patent expiry with a round of layoffs. | Astellas CEO said he doesn't ...
As of Friday, January 23, Burning Rock Biotech Limited’s BNR share price has dipped by 9.56%, which has investors questioning if this is right time to buy.
Regeneron Pharmaceuticals, Inc. nears a key earnings report after a strong JPM Healthcare update. Click here to find out why ...
Investor's Business Daily on MSN
Stock market falls, recovers on Trump's Greenland shifts; Intel, Netflix, Tesla key movers: Weekly review
The stock market plunged initially on President Trump's Greenland tariffs, but recovered as he backed off. Intel, Netflix, Tesla were key movers.
The Global Women Healthcare Market is primed for growth due to increasing government initiatives and advancements in FemTech and AI diagnostics. There's potential in addressing women's chronic and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback